Europe — Selling, general, and administrative expenses
Edwards Lifesciences Europe — Selling, general, and administrative expenses decreased by 26.3% to $71.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $73.40M to $71.80M. Over 3 years (FY 2022 to FY 2025), Europe — Selling, general, and administrative expenses shows an upward trend with a 10.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may reflect aggressive investment in market expansion or higher sales commissions, whereas a decrease could indicate cost-cutting measures or improved operational leverage.
Detailed definition
This metric encompasses the operating expenses required to support the sales, marketing, and administrative functions of...
Peer comparison
Comparable to regional SG&A allocations reported by multinational medical device companies.
ew_segment_europe_selling_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.25M | $58.25M | $58.25M | $58.25M | $65.15M | $65.15M | $65.15M | $65.15M | $71.40M | $70.90M | $65.00M | $75.30M | $73.40M | $74.20M | $70.00M | $97.40M | $71.80M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +11.8% | +0.0% | +0.0% | +0.0% | +9.6% | -0.7% | -8.3% | +15.8% | -2.5% | +1.1% | -5.7% | +39.1% | -26.3% |
| YoY Change | — | — | — | — | +11.8% | +11.8% | +11.8% | +11.8% | +9.6% | +8.8% | -0.2% | +15.6% | +2.8% | +4.7% | +7.7% | +29.3% | -2.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's europe — selling, general, and administrative expenses?
- Edwards Lifesciences (EW) reported europe — selling, general, and administrative expenses of $71.80M in Q1 2026.
- How has Edwards Lifesciences's europe — selling, general, and administrative expenses changed year-over-year?
- Edwards Lifesciences's europe — selling, general, and administrative expenses decreased by 2.2% year-over-year, from $73.40M to $71.80M.
- What is the long-term trend for Edwards Lifesciences's europe — selling, general, and administrative expenses?
- Over 3 years (2022 to 2025), Edwards Lifesciences's europe — selling, general, and administrative expenses has grown at a 10.6% compound annual growth rate (CAGR), from $233.00M to $315.00M.
- What does europe — selling, general, and administrative expenses mean?
- Operating costs for sales, marketing, and administration in the European region.